Could a patent rul­ing threat­en Mod­er­na’s Covid-19 vac­cine?

Up­date: Mod­er­na re­leased an up­dat­ed state­ment Fri­day af­ter­noon say­ing that the LNPs used in its Covid-19 vac­cine, mR­NA-1273, are not part of the dis­put­ed in­tel­lec­tu­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER